Safety, Tolerability, and Pharmacokinetics of REGN5069 in Healthy Volunteers

NCT03645746 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

56

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Volunteer

Interventions

DRUG: REGN5069
DRUG: Placebo

Sponsor

Regeneron Pharmaceuticals